Randomized Controlled Trials May Be Less Burdensome, FDA Guidance Says

Randomized controlled clinical trials of medical devices represent, in certain circumstances, the least burdensome route for sponsors to gain FDA approval, the agency maintains.

More from Archive

More from Medtech Insight